WiCON | Pharma China (Web Edition)

The Market

Industry News

Regulatory News

General Health

Legal/IPR News

Product/R&D News

API/Bulk Drug News

People in the News

Other News

Top News Worldwide

Editorials

Commentaries

Expert Opinions

Interviews

Case Studies

Company Profiles

Editor´s Picks

WiCON International Group
21 Bridge Street
Metuchen, NJ 08840,
USA
Tel/Fax: +1 801-751-5728
Email: info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Oriental Kenzo Plaza
Beijing, China
Tel: +86 10 84476010
Email:
info@pharmachinaonline.com

As MNCs Refocus on Innovative Drugs, Feel the Pulse of China's IP Landscape Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on latest market data, national VBP tender outcomes and mixe...
(9/2/2020)

NMPA Proposes Implementing Rules on Patent Linkage for Public Comments (9/22/2020)

NMPA and CNIPA issue Draft Patent Linkage Measures in China (9/18/2020)

China's Draft Patent Linkage Implementation Measures for Public Comment (9/17/2020)

Chinese Consumers Increasingly Prioritize Immune Health (9/16/2020)

Anheart Builds Its Oncology Pipeline Following Five Rs (9/15/2020)

With U.S.-China Relations Tremulous, Is China Still a Good Place to Do Business? (9/15/2020)

China Debates Cutting US Access to Drugs as Hostilities Spike (9/9/2020)

China Tightens Technology Export Control Rules (9/3/2020)

As MNCs Refocus on Innovative Drugs, Feel the Pulse of China's IP Landscape (9/2/2020)

China's Pre-Revenue Biopharma Players Continue To Be Embraced By Markets, Investors (9/1/2020)

McKinsey Report: Managing China's Growing Oncology Burden (8/30/2020)

Data-Driven Perspectives on US-China Business (8/28/2020)

Chinabio Partnering Panel Says Outlook Is Positive for Investments (8/28/2020)

China Could Weaponize Drug Exports to Retaliate Against US Chip Restrictions (8/26/2020)

Foreign Drug Giants Undercut by Up to 95% in China Bidding (8/21/2020)

Performance Review of A Share-Listed Chinese M... (9/25/2020) IQVIA: China Represents 11% of Global Vaccine ... (9/25/2020) Review of Chinese Pharma Licensing Trends 2015... (9/25/2020) Snapshot of R&D Spending of Listed Chinese Pha... (9/25/2020) Clover's Coronavirus Vaccine Candidate Showed ... (9/25/2020) (free) BioDuro and Sundia Tie Up to Become Industry L... (9/25/2020) (free) AstraZeneca to Market OM Pharma's Lyophilized ... (9/24/2020) AZ Ties Up with Samsung Biologics to Boost Asi... (9/24/2020) Fitch: China's Medical Insurance Scheme Reform... (9/23/2020) Athenex Granted IND in the U.S. for TCRT-ESO-A... (9/23/2020) (free) WiCON Publishes the China Pharmaceutical Guide... (9/23/2020) CDE Issues the Guidelines for Drug Clinical Tr... (9/22/2020) JD Health confirms Hong Kong IPO (9/22/2020) Nicox's ZERVIATE Granted Chinese IND Approval (9/22/2020) Genscript/Legend Executive under 'House Arrest... (9/22/2020)

Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ... Top 25 Global Pharmaceutical Companies by Market Cap 20...

IQVIA: China Represents 11% of Global Vaccine Market WiCON Publishes the China Pharmaceutical Guide 2020 (15... WiCON Publishes the China Pharmaceutical Guide 2020 (15... Snapshot of Chinese Internet Healthcare Market SMEI: Urban Hospital Chemical Drug Market Down Sharply ...

BioDuro and Sundia Tie Up to Become Industry Leading CR... Snapshot of R&D Spending of Listed Chinese Pharma Compa... Review of Chinese Pharma Licensing Trends 2015-2019 Performance Review of A Share-Listed Chinese MedPharm C... AZ Ties Up with Samsung Biologics to Boost Asian Manufa...

CDE Issues the Guidelines for Drug Clinical Trial Data ... CDE Solicits Comments Again over the Technical Docs on ... CDE Solicits Comments on the Technical Requirements for... NMPA Suspends Import, Sales and Use of Polichem's Nifur... CDE Issues Document on Re-registration of Foreign-made ...

Genscript/Legend Executive under 'House Arrest', Possib... Supreme Court and NHSA Enter MOU for Establishing Pharm... CNIPA Invalidates BMS‘s Chinese Patent for Low Dose En... Illumina Sues BGI Over Coronavirus Patent Infringement Chinese Biotech Researcher Pleads Guilty to Stealing Tr...

China Increases Prices of Key Drug Ingredients by Up To... U.S. Introduces A 'Buy American First' Pharma Executive... Fitch: No Near-Term Impact on Chinese API Makers as Pha... Indian Firms Challenged by API Price Hikes by Chinese S... Snapshot of the Chinese API Sector

Clover's Coronavirus Vaccine Candidate Showed Promise i... Athenex Granted IND in the U.S. for TCRT-ESO-A2, a TCR-... I-Mab Cleared in China for P1 Trial of Lemzoparlimab in... Nicox's ZERVIATE Granted Chinese IND Approval MorphoSys and I-Mab Cleared by FDA for IND of Antican...

Fitch: China's Medical Insurance Scheme Reform Neutral ... NHSA Publicizes the List of Drugs Passing Form Evaluati... NHSA Issues the Guidance Opinions for Establishing Drug... China Issues the Guidance Policy for Strengthening and ... Vice Premier Calls for Deepened Reform of Centralized D...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves Recent Executive Moves

USTR Satisfied with China's Implementatin of Phase 1 US... U.S.-China ESRC Hearing: China's Evolving Healthcare Sy... AmCham Survey: Supply Chain Challenges for US Companies... Upcoming Event: 2nd World Congress on Dermatology and A... Upcoming Event: XI International Exhibition of Equipmen...

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON to Hold Pharma China Annual F... WiCON Publishes the China Pharmaceu... WiCON Officially Publishes China Ph...